Oligoclonal banding analysis: assessing plasma use and time interval requirements for paired CSF and blood

Clin Chem Lab Med. 2025 Jun 26;63(11):e250-e253. doi: 10.1515/cclm-2025-0649. Print 2025 Oct 27.

Lily Olayinka^{1

2}, Yu Chen^{3

4

5}, Karina Rodriguez-Capote^{6

7}, Jessica L Gifford^{8

9}, Caitlin Buch⁸, Spencer Weber⁸, Michelle L Parker^{1

2}, Natalia Volodko^{1

2}, Mathew P Estey^{1

2}, Dustin Proctor^{1

2}, Ashley Newbigging^{1

2}, Pierre Bordeleau¹, Maggie Powell¹, Daniel R Beriault^{10

11}, Joseph Macri¹², Victoria Higgins^{1

2}

¹ Alberta Precision Labs, Edmonton, AB, Canada.
² Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
³ Department of Laboratory Medicine, Dr. Everett Chalmers Regional Hospital, Horizon Health Network, Fredericton, NB, Canada.
⁴ Department of Pathology, Dalhousie University, Halifax, NS, Canada.
⁵ Discipline of Laboratory Medicine, Memorial University, St John's, NL, Canada.
⁶ Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
⁷ Department of Pathology and Laboratory Medicine, Interior Health Authority, Kelowna, BC, Canada.
⁸ Alberta Precision Laboratories, Calgary, AB, Canada.
⁹ Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
¹⁰ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
¹¹ Department of Laboratory Medicine and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
¹² Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

No abstract available

Keywords: cerebrospinal fluid; multiple sclerosis; oligoclonal banding.

Publication types